Expert Opinion on Orphan Drugs
Q4IF0.8SJR0.392
GB
GBJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.392 | Q2 | 52.7% | |
| 2024 | — | — | 0.286 | Q2 | 44.3% | |
| 2023 | 0.8 | Q4 | 14.5% | 0.199 | Q3 | 35.0% |
| 2022 | 0.8 | Q4 | 12.7% | 0.238 | Q2 | 43.5% |
| 2021 | 1.0 | Q4 | 29.6% | 0.222 | Q3 | 42.3% |
| 2020 | — | — | 0.237 | Q3 | 42.1% | |
| 2019 | — | — | 0.311 | Q2 | 53.5% | |
| 2018 | — | — | 0.302 | Q2 | 50.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2167-8707
country
GBcoverage
2013-2024